Skip to content

Effect of Ginseng Decoction on Cardiopulmonary Function and Intestinal Microflora in Patients with Deficiency Cold Type of Phase II Heart Rehabilitation of Coronary Heart Disease

Effect of Ginseng Decoction on Cardiopulmonary Function and Intestinal Microflora in Patients with Deficiency Cold Type of Phase II Heart Rehabilitation of Coronary Heart Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075716
Enrollment
Unknown
Registered
2023-09-13
Start date
2023-09-15
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Experimental group:The combination of traditional Chinese and Western medicine with cardiac rehabilitation program was adopted for 3 months, and the control group was treated with ginseng decoction.
Control group:Standard Western cardiac rehabilitation protocol was adopted for 3 months.

Sponsors

Wuxi Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-85 years old, gender unlimited. (2) In the second stage of coronary heart disease cardiac rehabilitation. (4) The risk of coronary heart disease was divided into medium and low risk. (5) TCM syndrome differentiation is deficiency cold type. (6) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Combined with rheumatic heart disease, pulmonary heart disease, hypertrophic cardiomyopathy, severe valvular disease, acute myocarditis, acute pericarditis, aneurysm (dissection) and other cardiovascular diseases. Gastroenteritis, gastrointestinal ulcers, cirrhosis of the liver, chronic kidney failure, and other problems affecting the gut microbiota. (2) Uncontrolled metabolic diseases, such as hyperthyroidism and myxedema; Acute infection, malignant tumor, blood disease, thrombotic disease and other non-cardiac diseases. (3) Pregnant or lactating women. (4) physical disability or dysfunction; Mental disorders can't work together. (5) Antibiotics or probiotics have been used within 2 months before the collection of stool samples. (6) Patients who are participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
Treatment efficiency and TCM syndrome score;Cardiopulmonary exercise test;Tumor necrosis factor alpha;Interleukin-6;hs-CRP;mRNA levels of TLR-4/NF-?B;TMAO;Intestinal flora;

Secondary

MeasureTime frame
Ox-LDL;TC;LDL-c;HDL-C;TG;

Countries

China

Contacts

Public ContactChen Qiaofeng

Wuxi Mental Health Center

qiaofengchen@163.com+86 133 5811 0094

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026